Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.61 - $2.54 $25,558 - $40,322
-15,875 Reduced 4.06%
375,439 $679,000
Q2 2023

Aug 14, 2023

SELL
$1.14 - $1.95 $138,692 - $237,237
-121,660 Reduced 23.72%
391,314 $727,000
Q1 2023

May 12, 2023

BUY
$1.2 - $2.19 $615,568 - $1.12 Million
512,974 New
512,974 $682,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $71,623 - $366,950
98,115 New
98,115 $306,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $19B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.